2 Comments

hell yeah, welcome back

Expand full comment

Welcome back! Enjoy your writing. Just a comment on digital therapeutics. There are many efficacious digital therapeutics but because the 3 major PBMs control the merchandizing and prioritization of items on their formularies, I wonder if the PBM is a limiting factor in their adoption? What feature of a pbm platform actually showcases the availability or importance of these therapeutics? Further, working with many value based provider and health systems, I’ll tell you that many/most of the most enlightened providers don’t necessarily understand the whole area of digital therapeutics and their potential efficacy for patients.

Expand full comment